Our Team
Dr. Chaitanya R. Divgi
Chief Medical Officer with 30+ years in Nuclear Medicine.
Chaitanya is a Nuclear Medicine Physician and Scientist with 30+ years in Ivy League institutions, leading programs in Nuclear Oncology imaging & therapy. He is a world-renowned expert in nuclear medicine and tumor radiotherapy and went on to teach as a Professor at Memorial Sloan Kettering Cancer Center. Chaitanya has held many senior roles such as Chief of Molecular Imaging at the University of Pennsylvania, Vice-Chair of Radiology Research at Columbia University, and is currently CEO of Divgi Consulting.
Anwer Rizvi
President, 35+ years in medical isotope innovation.
Anwer offers an advanced level of global expertise in the theranostic molecular field. As a well-respected innovator, he brings extensive experience in the theranostic molecular field and a broad range of commercial expertise to business development at both the grass roots and global strategic levels of business, particularly across the US and Europe. Anwer has built and managed the development of over 43 cyclotron facilities worldwide. He has successfully served in numerous executive director and shareholder capacity positions. Prior to SpectronRx, Anwer Co-Founded Eastern Isotopes (later acquired by IBA) and went on to become the CEO for IBA Molecular.
Dr David Trump
Chief Radiochemist Ph.D. Radiochemist & Nuclear Pharmacy with 20+ years’ experience.
David has over 20 years of experience in many roles in nuclear medicine, including research and development, radiolabeling, manufacturing, quality control, oversight and regulatory submissions. Along with extensive industry experience and a Ph.D. in Radiochemistry and Nuclear Pharmacy, David teaches nuclear medicine classes at Radiological Technologies University. Prior to joining SpectronRx, he developed new radiopharmaceuticals for SpectronRx and Mayo Clinic.
John Zehner
CEO, Founder Nuclear Pharmacist with 25+ years in Radiopharmaceuticals.
With extensive experience in medical isotopes, John brings an unparalleled combination of experience and background to ScintiQuant. He has extensive experience in the pharmaceutical industry across the US and Europe and has held senior leadership roles in a range of biotech companies. With a background in Nuclear Pharmacy, John has impressively built and managed two 70 MeV’s and multiple PET cyclotrons. He has acquired a broad range of commercial expertise with FDA and NRC regulations. John’s leadership at SpectronRx has been a driving force behind our innovation and quality, where he has achieved various product approvals in the diagnostic and theronostic molecular isotope field. Prior to SpectronRx, John was Chief Operations Officer of Zevacor Molecular, Co-Founder of Eastern Isotopes (later acquired by IBA), and Co-Founder of Sofie (FKA Eastern Isotopes).
William (Bill) Monachino
Previous Founder & President of a top 30 Healthcare Consulting Firm.
Bill has extensive experience with leading hospital systems including Ascension, Vanderbilt and Seattle Children’s driving complex solutions across the enterprise. He is a focused and assiduous leader with a passion for helping others and brings his strong expertise in technology and consulting to SpectronRx and ScintiQuant.
